Lupin Announces Final FDA Approval of Cefdinir Capsules (PR Newswire via Yahoo! Finance)
Lupin Pharmaceuticals, Inc. announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Cefdinir Capsules, 300 mg.

ABIOMED Receives FDA Approval to Commence IMPELLA 2.5 U.S. Trial; Indication for Use is Support During High-Risk (FinanzNachrichten)
ABIOMED, Inc. (NASDAQ: ABMD) today announced that the U.S. Food and Drug Administration (FDA) granted approval for the Company to commence its pilot clinical trial immediately in the United States for the IMPELLA(R) 2.5 minimally invasive ventricular assist device (VAD). The approval is conditioned upon the Company's submission of additional information to the FDA over the next 45 days.

US FDA approves Lupin's Cefdinir (PharmaBiz)
The US FDA has approved Lupin's Abbreviated New Drug Application (ANDA) for Cefdinir capsules 300mg.